Beginning Cash: The amount of cash reported by the company on its previous statement.
Kronos Bio, Inc. (KRON) had Beginning Cash of $200.30M for the most recently reported fiscal year, ending 2022-12-31.
| Income Statement Financials | |
-- |
|
$-133.20M |
|
-- |
|
-- |
|
$137.12M |
|
$-137.12M |
|
$3.91M |
|
$-133.20M |
|
$-133.20M |
|
$-133.20M |
|
$-133.20M |
|
$-133.20M |
|
$-133.20M |
|
$-137.12M |
|
$-135.38M |
|
56.20M |
|
56.20M |
|
$-2.37 |
|
$-2.37 |
|
| Balance Sheet Financials | |
$244.29M |
|
$12.98M |
|
$50.65M |
|
$294.94M |
|
$21.49M |
|
-- |
|
$28.95M |
|
$50.44M |
|
$244.50M |
|
$244.50M |
|
$244.50M |
|
56.97M |
|
| Cash Flow Statement Financials | |
$-90.93M |
|
$-32.22M |
|
$0.85M |
|
|
Beginning Cash |
$200.30M |
$78.00M |
|
$-122.30M |
|
$31.14M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.37 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-91.50M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-54.48% |
|
-54.48% |
|
-45.16% |
|
-54.48% |
|
$4.29 |
|
$-1.63 |
|
$-1.62 |
|